Heart Disease News and Research

Latest Heart Disease News and Research

BioMedica Diagnostics’ flagship product monitors heart disease

BioMedica Diagnostics Inc, a company that uses innovative technology to link the medical needs of developed countries with those of less advantaged populations is growing.

3 May 2010

Majority of patients who appear healthy may be at risk for cardiovascular disease

Three separate studies announced today at the American Society of Hypertension Inc.'s 25th Annual Scientific Meeting and Exposition (ASH 2010) examined the cardiovascular consequences of relatively healthy patients - those who were asymptomatic and not classified as hypertensive or diabetic - and found that many patients who appear healthy may still be at risk for cardiovascular disease.

3 May 2010

CACS used to improve classification of risk for prediction of coronary heart disease events

Use of a score based on the amount of calcium in coronary arteries in addition to traditional risk factors improved the classification of risk for prediction of coronary heart disease events, and placed more individuals in the most extreme risk categories, according to a study in the April 28 issue of JAMA.

3 May 2010

FDA approves Abbott Prism Chagas test to screen blood, tissue and organ donors for T. cruzi

The U.S. Food and Drug Administration today approved a second test to screen blood, tissue and organ donors for a blood-borne parasite, Trypanosoma cruzi that causes Chagas disease, a serious and potentially fatal parasitic infection.

3 May 2010

Exercise tips for long-term fitness

From working out to eating right, knowing how to best live a healthy lifestyle can become confusing. The long-term health landscape continues to change as research into integrative medicine and genomic function evolves.

3 May 2010

Measuring children's blood pressure is complicated: Researchers

A Johns Hopkins Children's Center study of 2,500 patient records suggests that medical staff fails to check a child's blood pressure a fifth of the time, and is not recognizing what constitutes an abnormal reading in those whose blood pressure they do check.

3 May 2010

VIMOVO delayed-release tablets receive FDA approval

AstraZeneca and POZEN Inc. today announced the U.S. Food and Drug Administration has approved VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.

3 May 2010

Heart and liver transplant recipients at higher risk of developing lung cancer: Researchers

Heart and liver transplant recipients are at particularly high risk of developing lung cancer after receiving the donated organ, researchers report at the 2nd European Lung Cancer Conference. They are advising doctors to screen for such cancers in these patients to maximize the chance of detecting the malignancy early.

3 May 2010

Molecular imaging can help physicians identify aortic dissection: Research

According to research published in the May issue of The Journal of Nuclear Medicine, molecular imaging can help physicians identify aortic dissection-an often fatal blood vessel condition-and help guide treatment.

3 May 2010

New tool may help neurologists predict candidates for organ donation

A new tool may help neurologists predict which coma patients may be candidates for organ donation, according to a study published in the April 27, 2010, print issue of Neurology, the medical journal of the American Academy of Neurology.

3 May 2010

Dietary protein for overall health

The importance of high-quality protein foods in overall health was among the topics discussed this week at Experimental Biology 2010 in Anaheim, Calif. Researchers from a variety of institutions discussed studies that looked at varying levels of dietary protein intake to promote health throughout life including the role of protein in weight loss and muscle maintenance.

3 May 2010

Health outcomes explored at DDW 2010

Non-alcoholic fatty liver disease, which may soon be the leading indication for liver transplant, is found to be significantly associated with worse transplant outcomes. In addition, a new tool for diagnosing NAFLD represents an alternative to liver biopsy, which is more expensive and prone to complications, and ultrasound and alfafeprotein blood test screening are an effective alternative to CT scan and MRI for patients with cirrhosis at high risk for hepatocellular cancer.

3 May 2010

Vitamin E effective in treating NASH: Study

Vitamin E has been shown effective in treating nonalcoholic steatohepatitis, an obesity-associated chronic liver disease that can lead to cirrhosis, liver cancer, and death. NASH also is related to or a part of type 2 diabetes, lipid disorders and cardiovascular disease.

3 May 2010

New 4-D software program promises to improve treatment of lung cancer: Researchers

A new 4-dimensional software program promises to improve the treatment of lung cancer by allowing doctors to take the movement of breathing into account when administering radiotherapy, researchers announced today at the 2nd European Lung Cancer Conference in Geneva, Switzerland.

30 Apr 2010

New health law will penalize hospitals for poor quality

The new health law puts the nation's hospitals on strict notice. Either they improve the safety and quality of care for patients or the government will hit them where it hurts the most -- their revenue.

30 Apr 2010

Nuclear Pharm-Assist device for patients seeking care for cardiac, cancer diseases

Positron Corporation is a molecular imaging solutions company focused on Nuclear Cardiology states that its proprietary product line also includes unique solutions for the oncology community designed to enhance its position in this industry.

30 Apr 2010

Researchers use healthy person's complete genome sequence to predict risk for dozens of diseases

For the first time, researchers have used a healthy person's complete genome sequence to predict his risk for dozens of diseases and how he will respond to several common medications. The risk analysis, from the Stanford University School of Medicine, also incorporates more-traditional information such as a patient's age and gender and other clinical measurements.

30 Apr 2010

MicroStockProfit.com releases investment report featuring Cardium Therapeutics

MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

30 Apr 2010

Whole-genome analysis may play future role in clinical medicine: Study

Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patient's full genome for disease risks and unusual drug responses. The work brings closer to reality the concept that whole-genome sequencing might one day play a clinical role.

30 Apr 2010

Acorda Therapeutics reports AMPYRA gross sales of $3.4 million for first-quarter 2010

Acorda Therapeutics, Inc. today announced its financial results for the first quarter of 2010.

30 Apr 2010

Heart Disease News and Research

Latest Heart Disease News and Research

BioMedica Diagnostics’ flagship product monitors heart disease

Majority of patients who appear healthy may be at risk for cardiovascular disease

CACS used to improve classification of risk for prediction of coronary heart disease events

FDA approves Abbott Prism Chagas test to screen blood, tissue and organ donors for T. cruzi

Exercise tips for long-term fitness

Measuring children's blood pressure is complicated: Researchers

VIMOVO delayed-release tablets receive FDA approval

Heart and liver transplant recipients at higher risk of developing lung cancer: Researchers

Molecular imaging can help physicians identify aortic dissection: Research

New tool may help neurologists predict candidates for organ donation

Dietary protein for overall health

Health outcomes explored at DDW 2010

Vitamin E effective in treating NASH: Study

New 4-D software program promises to improve treatment of lung cancer: Researchers

New health law will penalize hospitals for poor quality

Nuclear Pharm-Assist device for patients seeking care for cardiac, cancer diseases

Researchers use healthy person's complete genome sequence to predict risk for dozens of diseases

MicroStockProfit.com releases investment report featuring Cardium Therapeutics

Whole-genome analysis may play future role in clinical medicine: Study

Acorda Therapeutics reports AMPYRA gross sales of $3.4 million for first-quarter 2010

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Heart Disease News and Research

Latest Heart Disease News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in